2CBFly-NBOMe
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2CBFly-NBOMe, also known as NBOMe-2C-B-FLY or as Cimbi-31, is a serotonin receptor modulator of the phenethylamine, DOx, and FLY families. It was indirectly derived from the phenethylamine hallucinogen 2C-B is and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25B-NBOMe.
- None
| |
 | |
| Clinical data | |
|---|---|
| Other names | 2C-B-FLY-NBOMe; NBOMe-2C-B-FLY; Cimbi-31; N-(2-Methoxybenzyl)-2C-B-FLY |
| Drug class | Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H22BrNO3 |
| Molar mass | 404.304 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Interactions
Pharmacology
Chemistry
History
2CBFly-NBOMe was discovered in 2002,[4] and further researched by Ralf Heim at the Free University of Berlin,[5] and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols.[6]
Society and culture
Legal status
Canada
2CBFly-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.[7]
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[8]
United States
2CBFly-NBOMe is not an explicitly controlled substance in the United States.[9] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.[10]